The Macrogen Biobank ensures the safe preservation of human-derived materials and offers valuable information to support groundbreaking medical research.
What is Macrogen Biobank? Macrogen Biobank is the first human biobank established by a non-medical institution in South Korea, officially approved by the Korea Disease Control and Prevention Agency(KDCA) in May 2024. We systematically collect and securely store
human-derived materials and related data. Through donor consent and deposit procedures, we gather and preserve resources such as blood, urine, tissues, and cells, providing them to researchers for various healthcare studies including disease cause investigation, new
drug development, and medical device innovation.
By collaborating with GenTok, a genetics and microbiome-based health management platform, Macrogen Biobank selectively collects and stores leftover samples from Direct-To-Consumer (DTC) genetic tests. This ensures that clinical samples are provided promptly to
researchers, supports innovation in biotechnology and digital health, and helps accelerate personalized medicine research.
The Macrogen Biobank is committed to empowering Korean researchers with unparalleled access to human biological resources. Key eligibility criteria include:
Pursuant to Article 42 of the Bioethics and Safety Act and Article 40 of its Enforcement Rules, the collection and provision of human bioresources require the donor's written consent.
Any bioresources for which the donor has not provided consent cannot be used for research purposes.
Key Guidelines
Once Written Consent Is Obtained
Donated human bioresources contribute to public health and scientific advancement, and can also benefit the health of the donor and their family.
Donors may withdraw consent at any time, upon which all collected samples will be immediately descarded to respect the donor's decision.
We provide optimal human bioresources to researchers to enhance the quality of research.